19th Annual International Ultmann Chicago Lymphoma Symposium
D

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differentiate and What To Do?

By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING David Scott
By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING David Scott
40 views
July 8, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Recommended

27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

656 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

901 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

304 views
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

282 views
31:12

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

400 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

98 views
40:38

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

244 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

858 views
16:27

Therapeutic Advances in T-Cell Lymphoma in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Barta

272 views
17:21

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

Daniel Addison

352 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.1K views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

432 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

819 views
13:34

EULAR 2023 Insights: From Pathogenesis to Therapy in Sjögren's Syndr…

EULAR 2023 Insights

H. Bootsma

364 views
05:38

Epcoritamab in NHL - Incidence and Management of CRS

GRACE

T. Phillips

171 views
26:58

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

114 views
22:38

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Indy Hematology Review

T. Phillips

151 views
15:03

Novel Combinations in Indolent Lymphoma

SOHO 2023 Eleventh Annual Meeting

P. Strati

273 views
13:58

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

120 views
26:31

Practical Aspects of Bispecifics in NHL: Supportive Care and Minimiz…

UChicago Medicine

K. Kelly

125 views
AUTOPLAY